.ANALYSIS FEATURE.06 August 2024.
A sizable randomized measured trial with cisgender women highlights the problems of adherence to a day-to-day dental preexposure treatment routine and also illustrates that twice-yearly shot of lenacapavir can sustain effective HIV prevention amounts over 6 months.